Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Blankenstein, Thomas Prof. Dr. (15) Daniel, Peter Prof. Dr. (2) Infante Duarte, Carmen (4) Ittermann, Bernd Dr. (2) Kammertöns, Thomas Dr. (4) Kopp, Joachim Dr. (3) Leisegang, Matthias Prof. Dr. rer. nat. (4) Mekle, Ralf (1) Millward, Jason Dr. (2) Niendorf, Thoralf Prof. Dr. (5) Paul, Friedemann Prof. Dr. med. (60) Siffrin, Volker (1) Waiczies, Helmar Dr. (2) Waiczies, Sonia PD Dr. (1) Willimsky, Gerald Dr. (5) (-) Pezzutto, Antonio Prof. Dr. (4) (-) Uckert, Wolfgang Prof. Dr. (5) 1997 (2) 1998 (2) 1999 (1) 2000 (2) 2003 (4) 2004 (2) 2005 (5) 2006 (1) 2007 (2) 2008 (1) (-) 2010 (2) (-) 2011 (4) 2013 (1) 2014 (2) (-) 2015 (3) 2016 (2) 2017 (1) 2018 (3) 2019 (1) 2020 (1) 2021 (1) 2022 (1) AG Müller/Dechend (ECRC) (59) AG Schreiber [ECRC] (1) Anchored Signalling (3) Animal Phenotyping (1) Biobank (4) Cardiac MRI (8) Cellular Neurosciences (2) Experimental Ultrahigh-Field MR (5) Genetics and Genomics of Cardiovascular Diseases (4) Genome Diversification & Integrity (7) Hypertension-caused End-Organ Damage (59) Hypertension-Mediated End-Organ Damage (59) Immune Regulation and Cancer (1) Magnetic Resonance (5) Mathematical Cell Physiology (12) Mathematical Modelling of Cellular Processes (1) Mechanism-based Cancer Therapies (1) Molecular Biology of Peptide Hormones (6) Molecular Epidemiology (4) Molecular Genetics of Chronic Inflammation and Allergic Disease (2) (-) Molecular Immunology and Gene Therapy (8) Molecular Physiology of Somatic Sensation (1) Myology (1) Nephrology and Inflammatory Vascular Diseases (1) (-) Out-patient Clinic for Neuroimmunology (1) Out-patient Clinic for Pediatric Allergology and Atopic Dermatitis (2) Proteome Dynamics (1) Proteomics and Metabolomics (1) Structural Biology of Membrane-Associated Processes (1) 9 Results: Active Filter: Pezzutto, Antonio Prof. Dr.Uckert, Wolfgang Prof. Dr.Molecular Immunology and Gene TherapyOut-patient Clinic for Neuroimmunology201020112015 Sort: Result score Newest to oldest Oldest to newest January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner July 19, 2011 / PLoS ONE Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells H. Waiczies S. Lepore N. Janitzek U. Hagen F. Seifert B. Ittermann B. Purfürst A. Pezzutto F. Paul T. Niendorf S. Waiczies April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel April 01, 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein April 15, 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
January 15, 2011 / Int J Cancer Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis D. Briesemeister D. Sommermeyer C. Loddenkemper R. Loew W. Uckert T. Blankenstein T. Kammertoens
April 15, 2010 / Clin Cancer Res T-cell receptor gene-modified T cells with shared renal cell carcinoma specificity for adoptive T-cell therapy M. Leisegang A. Turqueti-Neves B. Engels T. Blankenstein D.J. Schendel W. Uckert E. Noessner
July 19, 2011 / PLoS ONE Perfluorocarbon particle size influences magnetic resonance signal and immunological properties of dendritic cells H. Waiczies S. Lepore N. Janitzek U. Hagen F. Seifert B. Ittermann B. Purfürst A. Pezzutto F. Paul T. Niendorf S. Waiczies
April 01, 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
April 01, 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
April 01, 2011 / Gene Ther Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study J. Westermann A. Floercken G. Willimsky A. van Lessen J. Kopp A. Takvorian K. Joehrens A. Lukowsky C. Schoenemann B. Sawitzki H. Pohla R. Frank B. Doerken D.J. Schendel T. Blankenstein A. Pezzutto
July 28, 2011 / Blood The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed J. Popovic L.P. Li P.M. Kloetzel M. Leisegang W. Uckert T. Blankenstein
April 15, 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann